ERBB2 and breast carcinoma: Further analysis indicated that within the HR+ or HR− subtype, HER2-positive breast cancer revealed a different proportion of three molecular clusters divided by mutation and CNV profiles, while HER2-low and HER-zero breast cancer shared a similar proportion of three molecular clusters.